Enregistrement :
5
de
11
(2021-02-02
à
2021-10-01)
Subvention, Contribution ou autre avantage financier
Seeking funding to allow for increased research and development and other expenditures into two clinical-stage antibodies to treat acute respiratory distress syndrome (the primary cause of death from COVID-19) from the Industrial Research Assistance Program and the Strategic Innovation Fund.